Izrael - engleski - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - film coated tablets - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections in patients of 18 years and older• respiratory infections : - uncomplicated acute bacterial sinusitis (abs) - acute exacerbations of chronic bronchitis (aecb) megaxin tablets should be used to treat adequately diagnosed abs and aecb only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed to resolve the infection. - community acquired pneumonia, except severe cases. megaxin tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection. • community-acquired spontaneous and wound infections of the skin and skin structure.appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin tablets may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Izrael - engleski - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - film coated tablets - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections in patients of 18 years and older• respiratory infections : - uncomplicated acute bacterial sinusitis (abs) - acute exacerbations of chronic bronchitis (aecb) megaxin tablets should be used to treat adequately diagnosed abs and aecb only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed to resolve the infection. - community acquired pneumonia, except severe cases. megaxin tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection. • community-acquired spontaneous and wound infections of the skin and skin structure.appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin tablets may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Izrael - engleski - Ministry of Health

bayer israel ltd - sorafenib as tosylate - film coated tablets - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.nexavar is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/hürthle cell) thyroid carcinoma, refractory to radioactive iodine.

Izrael - engleski - Ministry of Health

bayer israel ltd - rivaroxaban - film coated tablets - rivaroxaban 2.5 mg - rivaroxaban - xarelto, co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel , is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.

Izrael - engleski - Ministry of Health

bayer israel ltd, israel - vericiguat - film coated tablets - vericiguat 10 mg - vericiguat - verquvo is indicated to reduce the risk of cardiovascular death and heart failure (hf) hospitalization following a hospitalization for heart failure or need for outpatient iv diuretics, in adults with symptomatic chronic hf and ejection fraction less than 45%.

Izrael - engleski - Ministry of Health

bayer israel ltd, israel - vericiguat - film coated tablets - vericiguat 2.5 mg - vericiguat - verquvo is indicated to reduce the risk of cardiovascular death and heart failure (hf) hospitalization following a hospitalization for heart failure or need for outpatient iv diuretics, in adults with symptomatic chronic hf and ejection fraction less than 45%.

Izrael - engleski - Ministry of Health

bayer israel ltd, israel - vericiguat - film coated tablets - vericiguat 5 mg - vericiguat - verquvo is indicated to reduce the risk of cardiovascular death and heart failure (hf) hospitalization following a hospitalization for heart failure or need for outpatient iv diuretics, in adults with symptomatic chronic hf and ejection fraction less than 45%.

Izrael - engleski - Ministry of Health

bayer israel ltd - drospirenone; estradiol as hemihydrate - film coated tablets - drospirenone 2 mg; estradiol as hemihydrate 1 mg - estradiol - estradiol - angeliq is indicated for hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women more than 1 year post menopause. prevention of postmenopausal osteoporosis in women with an increased risk of future osteoporosis fractures.

Izrael - engleski - Ministry of Health

bayer israel ltd - norethisterone acetate - tablets - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.

Izrael - engleski - Ministry of Health

bayer israel ltd - dienogest - tablets - dienogest 2 mg - dienogest and estrogen - dienogest and estrogen - treatment of endometriosis.